Artiva Biotherapeutics Inc
(ARTV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 40,235 | 53,504 |
| Marketable Securities | 145,193 | 23,467 |
| Receivables | 146 | 1,758 |
| TOTAL | $188,631 | $79,821 |
| Non-Current Assets | ||
| PPE Net | 6,370 | 8,096 |
| Other Non-Current Assets | 14,580 | 17,197 |
| TOTAL | $20,950 | $25,293 |
| Total Assets | $209,581 | $105,114 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 1,121 | 614 |
| Accrued Expenses | 7,392 | 8,017 |
| TOTAL | $12,253 | $12,227 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 10,643 | 254,902 |
| TOTAL | $10,687 | $254,902 |
| Total Liabilities | $22,940 | $267,129 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 24,363 | N/A |
| Common Shares | 3 | N/A |
| Retained earnings | -246,684 | -181,311 |
| Other shareholders' equity | -129 | 308 |
| TOTAL | $186,641 | $-162,015 |
| Total Liabilities And Equity | $209,581 | $105,114 |